NRX Pharmaceuticals, Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NRX Pharmaceuticals, Inc. stock issued during period, value, conversion of units for the quarter ending 2025-09-30 was $2.22M, a 167.67% increase year-over-year.
- NRX Pharmaceuticals, Inc. stock issued during period, value, conversion of units for the quarter ending 2025-06-30 was $5.98M.
- NRX Pharmaceuticals, Inc. stock issued during period, value, conversion of units for the quarter ending 2025-03-31 was $2.94M, a 635.00% increase year-over-year.
- NRX Pharmaceuticals, Inc. stock issued during period, value, conversion of units for the quarter ending 2024-09-30 was $829.00K.
- NRX Pharmaceuticals, Inc. stock issued during period, value, conversion of units for fiscal 2025 was $18.92M, a 222.68% increase from fiscal 2024.
- NRX Pharmaceuticals, Inc. stock issued during period, value, conversion of units for fiscal 2024 was $5.86M, a 497.05% increase from fiscal 2023.
- NRX Pharmaceuticals, Inc. stock issued during period, value, conversion of units for fiscal 2023 was $982.00K.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2025-12-31 | $18.92M 10-K · filed 2026-03-23 | |
| 2025-09-30 | $2.22M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $5.98M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $2.94M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $5.86M 10-K · filed 2026-03-23 | |
| 2024-09-30 | $829.00K 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $400.00K 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $982.00K 10-K · filed 2025-03-14 | |
| 2023-06-30 | $200.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |